| Year |
Citation |
Score |
| 2016 |
Alexandrov V, Brunner D, Menalled LB, Kudwa A, Watson-Johnson J, Mazzella M, Russell I, Ruiz MC, Torello J, Sabath E, Sanchez A, Gomez M, Filipov I, Cox K, Kwan M, et al. Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice. Nature Biotechnology. PMID 27376585 DOI: 10.1038/Nbt.3587 |
0.4 |
|
| 2016 |
Wheeler VC, Kovalenko M, Giordano J, Andrew M, Menalled L, Alexandrov V, Thiede C, Weidner J, Teichmann K, Tottey W, Cumming SA, Correia K, Barker D, Lager B, Flynn G, et al. B1 HTT CAG knock-in mice with pure and interrupted repeat tracts provide insight into the role of somatic expansion in HD pathogenesis Journal of Neurology, Neurosurgery & Psychiatry. 87: A9.2-A9. DOI: 10.1136/Jnnp-2016-314597.32 |
0.511 |
|
| 2014 |
Menalled L, Brunner D. Animal models of Huntington's disease for translation to the clinic: best practices. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1375-90. PMID 25216369 DOI: 10.1002/Mds.26006 |
0.456 |
|
| 2014 |
Farrar AM, Murphy CA, Paterson NE, Oakeshott S, He D, Alosio W, McConnell K, Menalled LB, Ramboz S, Park LC, Howland D, Brunner D. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease. Journal of Huntington's Disease. 3: 145-58. PMID 25062858 DOI: 10.3233/Jhd-130061 |
0.321 |
|
| 2014 |
Menalled LB, Kudwa AE, Oakeshott S, Farrar A, Paterson N, Filippov I, Miller S, Kwan M, Olsen M, Beltran J, Torello J, Fitzpatrick J, Mushlin R, Cox K, McConnell K, et al. Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease. Plos One. 9: e99520. PMID 24955833 DOI: 10.1371/Journal.Pone.0099520 |
0.444 |
|
| 2014 |
Smith MR, Syed A, Lukacsovich T, Purcell J, Barbaro BA, Worthge SA, Wei SR, Pollio G, Magnoni L, Scali C, Massai L, Franceschini D, Camarri M, Gianfriddo M, Diodato E, ... ... Menalled L, et al. A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. Human Molecular Genetics. 23: 2995-3007. PMID 24436303 DOI: 10.1093/Hmg/Ddu010 |
0.436 |
|
| 2013 |
Kudwa AE, Menalled LB, Oakeshott S, Murphy C, Mushlin R, Fitzpatrick J, Miller SF, McConnell K, Port R, Torello J, Howland D, Ramboz S, Brunner D. Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington's Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits. Plos Currents. 5. PMID 24042107 DOI: 10.1371/Currents.Hd.0Ab4F3645Aff523C56Ecc8Ccbe41A198 |
0.363 |
|
| 2013 |
Balci F, Oakeshott S, Shamy JL, El-Khodor BF, Filippov I, Mushlin R, Port R, Connor D, Paintdakhi A, Menalled L, Ramboz S, Howland D, Kwak S, Brunner D. High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease. Plos Currents. 5. PMID 23863947 DOI: 10.1371/Currents.Hd.124Aa0D16753F88215776Fba102Ceb29 |
0.503 |
|
| 2013 |
Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93. PMID 23220414 DOI: 10.1016/J.Nbd.2012.11.014 |
0.466 |
|
| 2012 |
Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. Plos One. 7: e49838. PMID 23284626 DOI: 10.1371/Journal.Pone.0049838 |
0.49 |
|
| 2012 |
Gafni J, Papanikolaou T, Degiacomo F, Holcomb J, Chen S, Menalled L, Kudwa A, Fitzpatrick J, Miller S, Ramboz S, Tuunanen PI, Lehtimäki KK, Yang XW, Park L, Kwak S, et al. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 7454-65. PMID 22649225 DOI: 10.1523/Jneurosci.6379-11.2012 |
0.402 |
|
| 2012 |
Cepeda-Prado E, Popp S, Khan U, Stefanov D, RodrÃguez J, Menalled LB, Dow-Edwards D, Small SA, Moreno H. R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6456-67. PMID 22573668 DOI: 10.1523/Jneurosci.0388-12.2012 |
0.407 |
|
| 2012 |
Menalled L, El-Khodor BF, Hornberger M, Park L, Howland D, Brunner D. Effect of the rd1 mutation on motor performance in R6/2 and wild type mice. Plos Currents. 4: RRN1303. PMID 22367489 DOI: 10.1371/Currents.Rrn1303 |
0.346 |
|
| 2011 |
Oakeshott S, Balci F, Filippov I, Murphy C, Port R, Connor D, Paintdakhi A, Lesauter J, Menalled L, Ramboz S, Kwak S, Howland D, Silver R, Brunner D. Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington's Disease. Plos Currents. 3: RRN1225. PMID 21479110 DOI: 10.1371/Currents.Rrn1225 |
0.464 |
|
| 2010 |
Menalled LB, Patry M, Ragland N, Lowden PA, Goodman J, Minnich J, Zahasky B, Park L, Leeds J, Howland D, Signer E, Tobin AJ, Brunner D. Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. Plos One. 5: e9793. PMID 20339553 DOI: 10.1371/journal.pone.0009793 |
0.385 |
|
| 2009 |
Menalled L, El-Khodor BF, Patry M, Suárez-Fariñas M, Orenstein SJ, Zahasky B, Leahy C, Wheeler V, Yang XW, MacDonald M, Morton AJ, Bates G, Leeds J, Park L, Howland D, et al. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models. Neurobiology of Disease. 35: 319-36. PMID 19464370 DOI: 10.1016/J.Nbd.2009.05.007 |
0.478 |
|
| 2005 |
Menalled LB. Knock-in mouse models of Huntington's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 465-70. PMID 16389309 DOI: 10.1602/neurorx.2.3.465 |
0.522 |
|
| 2003 |
Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. The Journal of Comparative Neurology. 465: 11-26. PMID 12926013 DOI: 10.1002/Cne.10776 |
0.396 |
|
| 2002 |
Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, Zeitlin S, Chesselet MF. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8266-76. PMID 12223581 DOI: 10.1523/Jneurosci.22-18-08266.2002 |
0.413 |
|
| 2002 |
Menalled LB, Chesselet MF. Mouse models of Huntington's disease. Trends in Pharmacological Sciences. 23: 32-9. PMID 11804649 DOI: 10.1016/S0165-6147(00)01884-8 |
0.471 |
|
| 2000 |
Menalled L, Zanjani H, MacKenzie L, Koppel A, Carpenter E, Zeitlin S, Chesselet MF. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Experimental Neurology. 162: 328-42. PMID 10739639 DOI: 10.1006/Exnr.1999.7327 |
0.439 |
|
| Show low-probability matches. |